Evidence map›Paper›PMID 32539299›Full record

ArticleAnnals of laboratory medicine2020

COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays.

Heungsup Sung, Kyoung Ho Roh, Ki Ho Hong, Moon-Woo Seong, Namhee Ryoo, Hyun Soo Kim, Jaehyeon Lee, So Yeon Kim, Sook Won Ryu, Mi-Na Kim and 4 more

Erratum issuedAbstract read
In one paragraph

Article in Annals of laboratory medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Heungsup SungDepartment of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.ORCID 0000-0002-6062-4451
Kyoung Ho RohDepartment of Laboratory Medicine, National Health Insurance Service, Ilsan Hospital, Goyang, Korea.ORCID 0000-0002-6291-9229
Ki Ho HongDepartment of Laboratory Medicine, Seoul Medical Center, Seoul, Korea.ORCID 0000-0002-5700-9036
Moon-Woo SeongDepartment of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0003-2954-3677
Namhee RyooDepartment of Laboratory Medicine, Keimyung University School of Medicine, Daegu, Korea.ORCID 0000-0001-8383-709X
Hyun Soo KimDepartment of Laboratory Medicine, Hallym University College of Medicine, Chuncheon, Korea.ORCID 0000-0002-7026-6715
Jaehyeon LeeDepartment of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju, Korea.ORCID 0000-0003-3211-8903
So Yeon KimDepartment of Laboratory Medicine, National Medical Center, Seoul, Korea.ORCID 0000-0003-1774-0382
Sook Won RyuDepartment of Laboratory Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.ORCID 0000-0002-8460-7111
Mi-Na KimDepartment of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.ORCID 0000-0002-4624-6925
Myung Guk HanCenter for Laboratory Control of Infectious Diseases, Korea Centers for Disease Control and Prevention, Osong, Korea.ORCID 0000-0002-3543-1826
Sang Won LeeCenter for Laboratory Control of Infectious Diseases, Korea Centers for Disease Control and Prevention, Osong, Korea.ORCID 0000-0003-0027-0134
Hyukmin LeeDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0002-8523-4126
Cheon Kwon YooCenter for Laboratory Control of Infectious Diseases, Korea Centers for Disease Control and Prevention, Osong, Korea.ORCID 0000-0002-8444-3620

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early detection of COVID-19 and immediate isolation of infected patients from the naive population are important to prevent further pandemic spread of the infection. Real-time reverse transcription (RT)-PCR to detect SARS-CoV-2 RNA is currently the most reliable diagnostic method for confirming COVID-19 worldwide. Guidelines for clinical laboratories on the COVID-19 diagnosis have been recently published by Korean Society for Laboratory Medicine and the Korea Centers for Disease Control and Prevention. However, these formal guidelines do not address common practical laboratory issues related to COVID-19 real-time RT-PCR testing and their solutions. Therefore, this guideline is intended as a practical and technical supplement to the "Guidelines for Laboratory Diagnosis of COVID-19 in Korea".

Indexed as

BetacoronavirusCoronavirus InfectionsCoronavirus Nucleocapsid ProteinsCOVID-19GuanidinesGuidelines as TopicHumansNasopharynxNucleocapsid ProteinsOpen Reading FramesOropharynxPandemicsPhosphoproteinsPneumonia, ViralReal-Time Polymerase Chain ReactionRepublic of KoreaCoronavirus Nucleocapsid ProteinsE protein, SARS coronavirusGuanidinesguanidine thiocyanatenucleocapsid phosphoprotein, SARS-CoV-2Nucleocapsid ProteinsPhosphoproteinsRNA, ViralThiocyanatesViral Envelope ProteinsViroporin ProteinsCoronavirus disease 2019GuidelinesKoreaLaboratory diagnosisReal-time RT-PCR

Identifiers

PMID32539299
PMCPMC7295959

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.